Silicon Laboratories (SLAB) Expected to Announce Quarterly Earnings on Tuesday

Silicon Laboratories (NASDAQ:SLABGet Free Report) will likely be releasing its Q3 2025 results before the market opens on Tuesday, November 4th. Analysts expect the company to announce earnings of $0.30 per share and revenue of $205.04 million for the quarter. Silicon Laboratories has set its Q3 2025 guidance at 0.200-0.400 EPS.Interested persons can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Tuesday, November 4, 2025 at 8:30 AM ET.

Silicon Laboratories (NASDAQ:SLABGet Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The semiconductor company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.09 by $0.02. Silicon Laboratories had a negative net margin of 14.88% and a negative return on equity of 7.21%. The business had revenue of $192.85 million during the quarter, compared to analyst estimates of $192.57 million. During the same period in the previous year, the business posted ($0.56) EPS. The company’s quarterly revenue was up 32.6% on a year-over-year basis. On average, analysts expect Silicon Laboratories to post $-1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Silicon Laboratories Stock Up 0.0%

Shares of NASDAQ:SLAB opened at $135.15 on Tuesday. The company has a market cap of $4.43 billion, a PE ratio of -41.97 and a beta of 1.51. Silicon Laboratories has a fifty-two week low of $82.82 and a fifty-two week high of $160.00. The firm has a 50-day simple moving average of $134.45 and a 200 day simple moving average of $129.56.

Insiders Place Their Bets

In related news, SVP Brandon Tolany sold 1,800 shares of the stock in a transaction dated Friday, August 29th. The shares were sold at an average price of $133.57, for a total value of $240,426.00. Following the completion of the transaction, the senior vice president owned 62,328 shares in the company, valued at $8,325,150.96. This represents a 2.81% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders have sold a total of 12,070 shares of company stock valued at $1,703,472 over the last three months. Corporate insiders own 1.60% of the company’s stock.

Institutional Trading of Silicon Laboratories

A number of hedge funds and other institutional investors have recently made changes to their positions in SLAB. Jones Financial Companies Lllp lifted its position in Silicon Laboratories by 121.4% during the 1st quarter. Jones Financial Companies Lllp now owns 496 shares of the semiconductor company’s stock worth $56,000 after buying an additional 272 shares in the last quarter. Canada Pension Plan Investment Board raised its stake in shares of Silicon Laboratories by 75.0% in the second quarter. Canada Pension Plan Investment Board now owns 700 shares of the semiconductor company’s stock worth $103,000 after acquiring an additional 300 shares during the last quarter. Amundi raised its stake in shares of Silicon Laboratories by 13.0% in the second quarter. Amundi now owns 8,768 shares of the semiconductor company’s stock worth $1,339,000 after acquiring an additional 1,009 shares during the last quarter. CANADA LIFE ASSURANCE Co lifted its position in shares of Silicon Laboratories by 4.0% during the second quarter. CANADA LIFE ASSURANCE Co now owns 33,258 shares of the semiconductor company’s stock worth $4,899,000 after purchasing an additional 1,269 shares in the last quarter. Finally, Tidal Investments LLC bought a new stake in shares of Silicon Laboratories during the second quarter valued at approximately $203,000.

Analyst Ratings Changes

Several research firms have recently commented on SLAB. Barclays upped their target price on Silicon Laboratories from $100.00 to $130.00 and gave the company an “equal weight” rating in a report on Tuesday, August 5th. KeyCorp increased their target price on Silicon Laboratories from $160.00 to $180.00 and gave the stock an “overweight” rating in a research report on Tuesday, July 8th. Stifel Nicolaus raised their target price on Silicon Laboratories from $144.00 to $160.00 and gave the company a “buy” rating in a research note on Friday, July 18th. Morgan Stanley lowered their price target on shares of Silicon Laboratories from $157.00 to $144.00 and set an “equal weight” rating for the company in a research report on Wednesday, August 6th. Finally, Susquehanna lifted their price objective on shares of Silicon Laboratories from $110.00 to $150.00 and gave the company a “neutral” rating in a research report on Tuesday, July 22nd. Five research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $151.13.

View Our Latest Research Report on SLAB

Silicon Laboratories Company Profile

(Get Free Report)

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.

Featured Articles

Earnings History for Silicon Laboratories (NASDAQ:SLAB)

Receive News & Ratings for Silicon Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silicon Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.